← FDA DRUG APPROVALS

FDA ANDA · ANDA070069

BETAMETHASONE VALERATE

Sponsor: COSETTE PHARMS NC

APPLICATION
ANDA070069
TYPE
ANDA
ORIGINAL APPROVAL
1985-12-19
LATEST ACTION
2001-08-30
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

BETA-VALPrescription
BETAMETHASONE VALERATE EQ 0.1% BASE · OINTMENT · TOPICAL

Approval history

2001-08-30Manufacturing (CMC) · Supplement 9AP
1996-06-13Manufacturing (CMC) · Supplement 8AP
1993-08-31Manufacturing (CMC) · Supplement 7AP
1992-10-13Manufacturing (CMC) · Supplement 6AP
1990-06-25Manufacturing (CMC) · Supplement 5AP
1989-07-18Manufacturing (CMC) · Supplement 3AP
1988-07-14Labeling · Supplement 2AP
1986-02-14Manufacturing (CMC) · Supplement 1AP
1985-12-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →